Antonina is particularly experienced in the life sciences sector where she advises a variety of pharmaceutical and biotech companies in relation to licensing arrangements, product acquisitions and disposals, research and development collaborations, manufacturing and supply arrangements, distribution agreements, material transfer agreements and quality and pharmacovigilance agreements.
Antonina also advises clients in different industry sectors on privacy and data protection issues.
Advising an international pharmaceutical business, for nearly a decade, on its commercial and licensing arrangements, its acquisition of various product portfolios, and on the commercial aspects of its corporate acquisitions
Lead commercial counsel on the disposal of a pharmaceutical business for £367m
Representing an oncology focused autologous cell therapy company in its commercial and clinical arrangements
Advising specialty pharma companies on their acquisition of various product portfolios, and on the commercial aspects of their corporate acquisitions
Advising, drafting and negotiating contractual documentation in relation to the implementation and maintenance of the London cycle hire scheme
Advising a provider of optimisation software in relation to its major licensing deals with global oil and gas companies
Advising an established provider of outside broadcasts, post-production and studio-based services in relation to its services agreements with major sports broadcasters, international sports governing bodies and committees for major sporting events
Do not send any information or documents that you want to have treated as secret or confidential. Providing information to McDermott via email links on this website or other introductory email communications will not create an attorney-client relationship; will not preclude McDermott from representing any other person or firm in any matter; and will not obligate McDermott to keep confidential the information you provide. McDermott cannot enter into an attorney-client relationship with you until McDermott has determined that doing so will not create a conflict of interest and until you and McDermott have entered into a written agreement or engagement letter that sets forth the terms of our relationship.